FRE - Fresenius SE & Co. KGaA - Stock & Dividends

Fresenius SE & Co. KGaA is a leading healthcare company that specializes in providing products and services for patients with chronic illnesses. The company operates through four distinct segments, each catering to specific healthcare needs.

The Fresenius Medical Care segment is dedicated to providing life-sustaining products and services for patients with chronic kidney failure. This includes a range of dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services that enable patients to receive the care they need.

The Fresenius Kabi segment focuses on the therapy and care of critically and chronically ill patients. This segment offers a diverse range of products, including I.V. generic drugs, biosimilar drugs for autoimmune diseases and oncology, enteral and parenteral nutrition products, and medical technologies such as disposables, infusions pumps, apheresis machines, and cell therapy devices.

In addition to its product offerings, Fresenius Kabi also provides a range of services, including clinical nutrition, medical devices, and pharmaceuticals, to support the care of critically and chronically ill patients.

The Fresenius Helios segment operates a network of clinical and nursing care facilities, providing patients with access to high-quality care and treatment.

The Fresenius Vamed segment offers a range of services for hospitals and other healthcare facilities, including operational management and consulting services. This segment also provides services directly to patients, supporting their care and recovery.

With a rich history dating back to 1912, Fresenius SE & Co. KGaA has established itself as a trusted and reliable partner in the healthcare industry. Headquartered in Bad Homburg vor der Höhe, Germany, the company continues to innovate and expand its services to meet the evolving needs of patients and healthcare providers around the world.